SafeBeat Rx App
Overview
The SafeBeat Rx App is an AI-powered medical tool developed by SafeBeat Rx, Inc. that focuses on cardiac care workflows, particularly ECG analysis and remote therapeutic monitoring. It is designed to assist clinicians in assessing patient information and guiding cardiac care.
- What it does: The SafeBeat Rx App utilizes proprietary machine learning algorithms for ECG interpretation and to provide treatment management recommendations. It aims to streamline the process of remote therapeutic monitoring by integrating with third-party FDA-cleared cardiac monitoring devices, such as mobile ECGs, mobile cardiac telemetry, and implantable cardiac monitors. The app also includes explainable AI and custom tools to display diagnostic information and patient-specific treatment steps.
- Who it is for: This tool is intended for clinicians, particularly those involved in cardiology and electrophysiology, who manage patients requiring cardiac monitoring and medication titration. It is being developed with the goal of expanding access to antiarrhythmic drugs for atrial fibrillation patients, especially in rural and minority populations, by enabling safe home-based monitoring during drug initiation.
- How it fits a clinical or practice workflow: The SafeBeat Rx App is designed to be used from a mobile phone, allowing clinicians to remotely monitor patients and receive AI-based insights for treatment decisions. It aims to support outpatient drug loading and potentially reduce the need for three-day hospitalizations typically required for initiating certain oral cardiac medications. The platform integrates with various remote patient monitoring technologies, including remote therapeutic monitoring and cardiac implantable electronic device monitoring.
- Notable capabilities: Key capabilities include specialized ECG analysis, AI-driven QTc measurement with high accuracy, and the ability to recommend antiarrhythmic drug dosing. The software is being developed to go beyond diagnostics to guide cardiac care and treatment management.
The SafeBeat Rx App is currently under development and is limited to investigational use only. A 510(k) application for approval of its QTc algorithm is underway with the FDA.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered treatment support
- Cardiac arrhythmia monitoring
- Pharmacological treatment guidance
- Patient safety enhancement
- Data-driven insights
Use Cases
- Supporting medication management for arrhythmia patients
- Monitoring patients on antiarrhythmic drugs
- Assisting in treatment plan adjustments for cardiac arrhythmias
- Enhancing patient safety during pharmacological treatment
Details
| Category | Cardiology AI, Pharmacology & Dosing AI |
| Pricing | Unknown — unknown |
| Deployment | Mobile App |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Cleared AI-estimated The SafeBeat Rx App is listed on the FDA AI/ML-Enabled Medical Device List, indicating it has received FDA clearance as a medical device. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Critical Care, Emergency Medicine |
What the Web Says
SafeBeat Rx is an AI-powered ECG platform designed to move beyond diagnostics to recommend treatment for cardiac conditions, particularly atrial fibrillation. The app aims to enable safe at-home initiation of antiarrhythmic drugs, which traditionally require hospitalization. It leverages machine learning to automate QTc measurements from ECGs and provides treatment recommendations with high accuracy compared to physicians.
Overall: PositiveStrengths
- Potential to dramatically improve care for patients requiring in-patient monitoring for drug initiation, improving patient care and workflows.
- Ability to expand access to life-saving medications, especially for minority and rural populations who face barriers to hospitalization.
- High QTc accuracy (5u00b17 ms) and 90% accuracy in recommending antiarrhythmic drug dosing compared to physicians.
- Designed by clinicians for clinicians, with streamlined software for mobile use and explainable AI.
- Addresses a critical gap in post-discharge cardiac surveillance and offers a novel approach to guideline-adherent pharmacological disease management.
- Potential to reduce healthcare costs by enabling home-based care and reducing hospital readmissions.
Limitations
- The product is currently under development and limited to investigational use only.
- No readily available reviews from general users or a broad range of tech reviewers, G2, or Capterra, suggesting it's not yet widely adopted or publicly accessible for general review.
- Limited information on potential challenges or drawbacks from a user experience perspective (e.g., app interface, ease of use for patients).
- The Reddit search for 'heart rate monitor app' did not specifically mention SafeBeat Rx, indicating a lack of public discussion on that platform.
- Competitors offer broader health monitoring capabilities or established market presence.
Based on reviews from: SafeBeat Rx u2013 Powering Cardiac Therapeutics u2013 All From Your Phone, SafeBeat Rx-Moving ECG AI Beyond Diagnostics to Recommending Treatment - PubMed, Novel, automated mobile heart rhythm analysis technology to start antiarrhythmic medications safely at home - NIH RePORTER, Safebeat Rx - Master of Translational Medicine - UC Berkeley & UCSF, From Software Release Bottlenecks to Automated Velocity: SafeBeat's Journey with Greenlight Guru, SafeBeat Rx-Moving ECG AI Beyond Diagnostics to Recommending Treatment | Request PDF - ResearchGate, SafeBeat Rx Funding | $5M-$10M Revenue | Complete Analysis - Extruct AI, Top 10 SafeBeat Alternatives & Competitors in 2026 - G2, SafeBeat: Guiding cardiac therapeutics - all from your phone - Y Combinator
Last updated: 2026-08-19
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate SafeBeat Rx App
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for SafeBeat Rx App.
How do I choose the right birth control method?#birthcontrol #rightchoice #womenshealth #womenhealth
Dr Rajeshwari Reddy
